表紙
市場調査レポート

糖鎖生物学市場:製品別(酵素:グリコシルトランスフェラーゼ、ノイラミニダーゼ、グリコシダーゼ、設備:HPLC、質量分析、MALDI-TOF、キットおよび試薬)、用途別(免疫学、腫瘍学)、エンドユーザー別の世界市場予測

Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments (HPLC, Mass Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) & by End User - Global Forecast to 2019

発行 MarketsandMarkets 商品コード 315373
出版日 ページ情報 英文 198 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
糖鎖生物学市場:製品別(酵素:グリコシルトランスフェラーゼ、ノイラミニダーゼ、グリコシダーゼ、設備:HPLC、質量分析、MALDI-TOF、キットおよび試薬)、用途別(免疫学、腫瘍学)、エンドユーザー別の世界市場予測 Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments (HPLC, Mass Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) & by End User - Global Forecast to 2019
出版日: 2014年09月30日 ページ情報: 英文 198 Pages
概要

世界の糖鎖生物学市場は2014年に5億1,238万米ドル、2012〜2019年のCAGRは12%となりました。2019年には9億2,811万米ドルに達すると予測されています。製薬会社やバイオテクノロジー企業が研究開発費を急速に拡大し、プロテオミクスや糖鎖私物学の研究に対する資金が拡大したこと同市場の成長を大きく支える二大要因となっています。さらに、癌やアルツハイマー病、パーキンソン病などの慢性感染症などがさらに研究を促しています。

当レポートは、世界の糖鎖生物学市場について調査し、用途別、エンドユーザー別、製品別、および地域別の動向、市場に参入する主要企業のシェアとプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

  • 世界の糖鎖生物学市場における豊富な機会
  • 地域別ライフサイクル分析

第5章 市場概要

  • イントロダクション
  • 市場セグメンテーション
    • 製品別
    • 用途別
    • エンドユーザー別
  • 促進因子
  • 阻害因子
  • 機会
  • 課題

第6章 業界動向

  • イントロダクション
  • バリューチェーン分析
  • サプライチェーン分析
  • ポーターズファイブフォース分析
  • 戦略的ベンチマーキング

第7章 製品別市場

  • イントロダクション
  • 酵素
    • グリコシダーゼ
    • グリコシルトランスフェラーゼ
    • ノイラミニダーゼ
    • シアリルトランスフェラーゼ
  • 設備
    • 抗体アレイ
    • HPLC
    • レクチンアレイ
    • MALDI-TOF
    • 質量分析
    • その他
  • キット
    • グリカンラベリングキット
    • グリカン精製キット
    • グリカンリリースキット
    • その他
  • 試薬
    • 糖タンパク質
    • 単糖
    • オリゴ糖
    • その他

第8章 用途別市場

  • イントロダクション
  • 診断
  • 創薬・薬剤開発
  • 免疫学
  • 腫瘍学
  • その他

第9章 エンドユーザー別市場

  • イントロダクション
  • 学術研究機関
  • CRO
  • 製薬会社・バイオテクノロジー企業

第10章 地域別市場

  • イントロダクション
  • アジア
  • 欧州
  • 北米
  • その他

第11章 競合環境

  • 市場シェア分析:糖鎖生物学酵素、キット、試薬市場
  • 市場シェア分析:糖鎖生物学設備市場
  • 競合動向
    • 新製品上市
    • 協定、提携、連携
    • 買収
    • 拡大
    • その他

第12章 企業プロファイル

第13章 付録

図表

目次
Product Code: BT 2776

Glycomics is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes such as cell recognition, immune response, cell-to-cell interaction, infection and inflammation. These processes are dependent on the intricate glycan structures present on interacting biomolecules. Advanced technologies such as high-throughput mass spectroscopy, glycan microarrays, and carbohydrate chemistry are helping to unravel the complexity resulting from this diversity.

This report segment the global glycomics market by application, end users, products, and geographies. The application segments included in this report are diagnostics; drug discovery and development; immunology; oncology; and other applications. The end-user segments of this market are academic research institutes, contract research organizations, and pharmaceutical and biotechnology companies. The product segments included in this report are enzymes; instruments; kits; and reagents. Glycosidases; glycosyltransferases; neuraminidases; sialyltransferases; and other enzymes are subsegments of the enzymes product segment. Antibody arrays; HPLC; lectin arrays; MALDI-TOF; mass spectrometers; and other glycomics instruments are subsegments of the instruments product segment. Glycan labeling kits; glycan purification kits; glycan release kits; and other glycomics kits are subsegments of the kits market. Glycoproteins; monosaccharaides; oligosaccharides; and other glycomics reagents are subsegments of the reagents product segment.

The geographic segments included in this report are Asia, Europe, North America and Rest of the World (RoW). Asia is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada, and the U.S. RoW encompasses the Middle East and Africa, Pacific and Oceania, and South America.

The key drivers for this market are the rising R&D expenditure by pharmaceutical and biotech companies, and increasing public and private funding for proteomics and glycomics research. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the glycomics enzymes, instruments, kits, and reagents market.

A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global glycomics enzymes, instruments, kits, and reagents market and its subsegments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their glycomics enzymes, instruments, kits and reagents market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the glycomics enzymes, instruments, kits and reagents market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of top players in the glycomics enzymes, instruments, kits and reagents market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the glycomics market
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the glycomics market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various glycomics enzymes, instruments, kits and reagents products across geographies
  • Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the glycomics enzymes, instruments, kits and reagents market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Markets Covered
  • 1.3. Stakeholders
  • 1.4. Market Scope

2. Research Methodology

  • 2.1. Description of the Glycomics Demand Model
    • 2.1.1. Growth in R&D Expenditure
    • 2.1.2. Increasing Number of Biotechnology Patents
  • 2.2. Market Size Estimation
  • 2.3. Market Crackdown and Data Triangulation
  • 2.4. Market Share Estimation
    • 2.4.1. Key Data From Secondary Sources
    • 2.4.2. Key Data From Primary Sources
      • 2.4.2.1. Key Industry Insights
    • 2.4.3. Assumptions

3. Executive Summary

4. Premium Insights

  • 4.1. Lucrative Opportunities in the Global Glycomics Market
  • 4.2. Life Cycle Analysis, By Geography

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Glycomics Market, By Product
    • 5.2.2. Glycomics Market, By Application
    • 5.2.3. Glycomics Market, By End User
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Increasing Government and Private Funding for Proteomics and Glycomics Research
      • 5.3.1.2. Increasing Pharmaceutical and Biotechnology R&D Expenditure
      • 5.3.1.3. Growing Proteomics Market
      • 5.3.1.4. Technological Advancements for Glycomics Research
    • 5.3.2. Restraints
      • 5.3.2.1. High Degree of Consolidation Acts As An Entry Barrier for New Entrants
    • 5.3.3. Opportunities
      • 5.3.3.1. Increased Use of Personalized Medicine
      • 5.3.3.2. Developing Countries Present Significant Opportunities for the Glycomics Market
    • 5.3.4. Challenges
      • 5.3.4.1. Stringent Regulatory Frameworks Act As A Major Challenge

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Value Chain Analysis
  • 6.3. Supply Chain Analysis
    • 6.3.1. Key Influencers
  • 6.4. Porter's Five forces Analysis
    • 6.4.1. Threat From New Entrants
    • 6.4.2. Threat From Substitutes
    • 6.4.3. Bargaining Power of Buyers
    • 6.4.4. Bargaining Power of Suppliers
    • 6.4.5. Intensity of Rivalry
  • 6.5. Strategic Benchmarking
    • 6.5.1. New Product Launches

7. Glycomics Market, By Product

  • 7.1. Introduction
  • 7.2. Enzymes
    • 7.2.1. Glycosidases
    • 7.2.2. Glycosyltransferases
    • 7.2.3. Neuraminidases
    • 7.2.4. Sialyltransferases
    • 7.2.5. Other Enzymes
  • 7.3. Instruments
    • 7.3.1. Antibody Arrays
    • 7.3.2. HPLC
    • 7.3.3. Lectin Arrays
    • 7.3.4. Maldi-TOF
    • 7.3.5. Mass Spectrometry
    • 7.3.6. Other Instruments
  • 7.4. Kits
    • 7.4.1. Glycan Labeling Kits
    • 7.4.2. Glycan Purification Kits
    • 7.4.3. Glycan Release Kits
    • 7.4.4. Other Kits
  • 7.5. Reagents
    • 7.5.1. Glycoproteins
    • 7.5.2. Monosaccharides
    • 7.5.3. Oligosaccharides
    • 7.5.4. Other Reagents

8. Glycomics Market, By Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Discovery & Development
  • 8.4. Immunology
  • 8.5. Oncology
  • 8.6. Other Applications

9. Glycomics Market, By End User

  • 9.1. Introduction
  • 9.2. Academic Research Insitutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Geographic Analysis

  • 10.1. Introduction
  • 10.2. Asia
    • 10.2.1. China
    • 10.2.2. India
    • 10.2.3. Japan
    • 10.2.4. Rest of Asia
  • 10.3. Europe
    • 10.3.1. France
    • 10.3.2. Germany
    • 10.3.3. Italy
    • 10.3.4. Spain
    • 10.3.5. U.K.
    • 10.3.6. Roe
  • 10.4. North America
    • 10.4.1. Canada
    • 10.4.2. U.S.
  • 10.5. ROW
    • 10.5.1. Middle East and Africa
    • 10.5.2. Pacific and Oceania
    • 10.5.3. South America

11. Competitive Landscape

  • 11.1. Overview
  • 11.2. Market Share Analysis, Glycomics Enzymes, Kits, and Regents Market
  • 11.3. Market Share Analysis, Glycomics Instruments Market
  • 11.4. Competitive Situation and Trends
    • 11.4.1. New Product Launches
    • 11.4.2. Agreements, Partnerships, and Collaborations
    • 11.4.3. Acquisitions
    • 11.4.4. Expansions
    • 11.4.5. Other Developments

12. Company Profiles

  • 12.1. Introduction
  • 12.2. Bruker Corporation
  • 12.3. New England Biolabs
  • 12.4. Shimadzu Corporation
  • 12.5. Sigma-Aldrich Corporation
  • 12.6. Takara Bio
  • 12.7. Waters Corporation
  • 12.8. Agilent Technologies, Inc.
  • 12.9. Danaher Corporation
  • 12.10. Prozyme
  • 12.11. Thermo Fisher Scientific

13. Appendix

  • 13.1. Insights of Industry Experts
  • 13.2. Discussion Guide
  • 13.3. Introducing Rt: Real Time Market Intelligence
  • 13.4. Available Customizations
  • 13.5. Related Reports

List of Tables

  • Table 1: Glycomics Market Size, By Product, 2012-2019 ($Million)
  • Table 2: Glycomics Enzymes Market, By Product, 2012-2019 ($Million)
  • Table 3: Glycomics Enzymes Market, By Geography, 2012-2019 ($Million)
  • Table 4: Glycosidases Enzymes Market, By Geography, 2012-2019 ($Million)
  • Table 5: Glycosyltransferases Enzymes Market, By Geography, 2012-2019 ($Million)
  • Table 6: Neuraminidases Enzymes Market, By Geography, 2012-2019 ($Million)
  • Table 7: Sialyltransferases Enzymes Market, By Geography, 2012-2019 ($Million)
  • Table 8: Other Glycomics Enzymes Market, By Geography, 2012-2019 ($Million)
  • Table 9: Glycomics Instruments Market, By Product, 2012-2019 ($Million)
  • Table 10: Glycomics Instruments Market, By Geography, 2012-2019 ($Million)
  • Table 11: Antibody Arrays Instruments Market, By Geography, 2012-2019 ($Million)
  • Table 12: HPLC Instruments Market, By Geography, 2012-2019 ($Million)
  • Table 13: Lectin Arrays Instruments Market, By Geography, 2012-2019 ($Million)
  • Table 14: Maldi-TOF Instruments Market, By Geography, 2012-2019 ($Million)
  • Table 15: Mass Spectrometry Instruments Market, By Geography, 2012-2019 ($Million)
  • Table 16: Other Glycomics Instruments Market, By Geography, 2012-2019 ($Million)
  • Table 17: Glycomics Kits Market, By Product, 2012-2019 ($Million)
  • Table 18: Glycomics Kits Market, By Geography, 2012-2019 ($Million)
  • Table 19: Glycan Labeling Kits Market, By Geography, 2012-2019 ($Million)
  • Table 20: Glycan Purification Kits Market, By Geography, 2012-2019 ($Million)
  • Table 21: Glycan Release Kits Market, By Geography, 2012-2019 ($Million)
  • Table 22: Other Glycomics Kits Market, By Geography, 2012-2019 ($Million)
  • Table 23: Glycomics Reagents Market, By Product, 2012-2019 ($Million)
  • Table 24: Glycomics Reagents Market, By Geography, 2012-2019 ($Million)
  • Table 25: Glycoproteins Reagents Market, By Geography, 2012-2019 ($Million)
  • Table 26: Monosaccharides Reagents Market, By Geography, 2012-2019 ($Million)
  • Table 27: Oligosaccharides Reagents Market, By Geography, 2012-2019 ($Million)
  • Table 28: Other Glycomics Reagents Market, By Geography, 2012-2019 ($Million)
  • Table 29: Glycomics Market Size, By Application, 2012-2019 ($Million)
  • Table 30: Glycobiology Market Size for Diagnostics, By Region, 2012-2019 ($Million)
  • Table 31: Glycomics Market Size for Drug Discovery and Development, By Region, 2012-2019 ($Million)
  • Table 32: Market Size for Immunology, By Geography, 2012-2019 ($Million)
  • Table 33: Market Size for Oncology, By Geography, 2012-2019 ($Million)
  • Table 34: Market Size for Other Applications, By Geography, 2012-2019 ($Million)
  • Table 35: Market Size, By End User, 2012-2019 ($Million)
  • Table 36: Market Size for Academic Research Institutes, By Geography, 2012-2019 ($Million)
  • Table 37: Market Size for Contract Research Organizations, By Geography, 2012-2019 ($Million)
  • Table 38: Market Size for Pharmaceutical & Biotechnology Companies, By Geography, 2012-2019 ($Million)
  • Table 39: Glycomics Market, By Geography, 2012-2019 ($Million)
  • Table 40: Asia: Glycomics Market, By Geography, 2012-2019 ($Million)
  • Table 41: Asia: Market, By End User, 2012-2019 ($Million)
  • Table 42: Asia: Glycomics Market, By Product, 2012-2019 ($Million)
  • Table 43: Asia: Glycobiology Enzymes Market, By Type, 2012-2019 ($Million)
  • Table 44: Asia: Glycomics Instruments Market, By Type, 2012-2019 ($Million)
  • Table 45: Asia: Glycomics Kits Market, By Type, 2012-2019 ($Million)
  • Table 46: Asia: Glycomics Reagents Market, By Type, 2012-2019 ($Million)
  • Table 47: Asia: Glycobiology Market, By Application, 2012-2019 ($Million)
  • Table 48: Europe: Glycomics Market, By Geography, 2012-2019 ($Million)
  • Table 49: Europe: Glycobiology Market, By End User, 2012-2019 ($Million)
  • Table 50: Europe: Glycomics Market, By Product, 2012-2019 ($Million)
  • Table 51: Europe: Glycomics Enzymes Market, By Type, 2012-2019 ($Million)
  • Table 52: Europe: Glycobiology Instruments Market, By Type, 2012-2019 ($Million)
  • Table 53: Europe: Glycomics Kits Market, By Type, 2012-2019 ($Million)
  • Table 54: Europe: Glycomics Reagents Market, By Type, 2012-2019 ($Million)
  • Table 55: Europe: Market, By Application, 2012-2019 ($Million)
  • Table 56: North America: Glycomics Market, By Geography, 2012-2019 ($Million)
  • Table 57: North America: Glycomics Market, By End User, 2012-2019 ($Million)
  • Table 58: North America: Glycobiology Market, By Product, 2012-2019 ($Million)
  • Table 59: North America: Glycomics Enzymes Market, By Type, 2012-2019 ($Million)
  • Table 60: North America: Glycomics Instruments Market, By Type, 2012-2019 ($Million)
  • Table 61: North America: Glycomics Kits Market, By Type, 2012-2019 ($Million)
  • Table 62: North America: Glycomics Reagents Market, By Type, 2012-2019 ($Million)
  • Table 63: North America: Market, By Application, 2012-2019 ($Million)
  • Table 64: ROW: Glycomics Market, By Geography, 2012-2019 ($Million)
  • Table 65: ROW: Glycomics Market, By End User, 2012-2019 ($Million)
  • Table 66: ROW: Glycobiology Market, By Product, 2012-2019 ($Million)
  • Table 67: ROW: Glycomics Enzymes Market, By Type, 2012-2019 ($Million)
  • Table 68: ROW: Glycomics Instruments Market, By Type, 2012-2019 ($Million)
  • Table 69: ROW: Glycobiology Kits Market, By Type, 2012-2019 ($Million)
  • Table 70: ROW: Glycomics Reagents Market, By Type, 2012-2019 ($Million)
  • Table 71: ROW: Market, By Application, 2012-2019 ($Million)
  • Table 72: New Product Launches, 2011-2014
  • Table 73: Agreements, Collaborations, and Partnerships, 2011-2014
  • Table 74: Acquisitions, 2011-2014
  • Table 75: Expansions, 2011-2014
  • Table 76: Other Developments, 2012-2013

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Increased R&D Expenditure on Glycomics Will Drive the Global Market
  • Figure 3: Increasing Number of Biotechnology Patents Reflect the Increased Research in the Glycomics Market
  • Figure 4: Bottom-Up Approach
  • Figure 5: Top-Down Approach
  • Figure 6: Break Down of Primary Interviews: By Company Type, Designation, & Region
  • Figure 7: Enzymes Are Expected to Be the Fastest-Growing Product Segment in the forecast Period
  • Figure 8: Glycosidases Has the Largest Share of the Glycobiology Enzymes Market
  • Figure 9: Mass Spectrometry is Expected to Grow At the Highest Rate in the forecast Period
  • Figure 10: Glycan Release Kits to Dominate the Glycomics Kits Market
  • Figure 11: Oligosaccharides Command the Largest Share of the Glycomics Reagents Market
  • Figure 12: Increasing Funding in Glycobiology and Proteomics Research Will Drive the North American Glycomics Market
  • Figure 13: Attractive Opportunities in Market
  • Figure 14: Glycomics Enzymes to Account for Largest Market Share (2014)
  • Figure 15: North America to Account for Largest Share of the Global Glycomics Market (2014)
  • Figure 16: Asia Holds Lucrative Growth Opportunities
  • Figure 17: Glycomics Market Segmentation, By Product
  • Figure 18: Glycobiology Market Segmentation, By Application
  • Figure 19: Glycobiology Market Segmentation, By End User
  • Figure 20: Increasing Government and Private Funding for Proteomics and Glycomics Research Will Spur the Demand for Glycomics Products
  • Figure 21: Value Chain Analysis (2014): Major Value is Added During Manufacturing and Assembly Phase
  • Figure 22: Supply Chain: Direct Distribution is the Most Prefered Strategy Followed By Prominent Companies
  • Figure 23: Porter's Five forces Analysis - High Capital Investment for R&D and Manufacturing Glycommics Products Will Restrict the Entry of New Player
  • Figure 24: Strategic Bench Marking: All Market Leaders Adopted Organic Growth Strtaegies of New Product Launches
  • Figure 25: Market Segmentation, By Product
  • Figure 26: Market Size, By Product, 2014 (Market Size and Growth Rates)
  • Figure 27: Glycomic Enzymes Market, By Products
  • Figure 28: Glycosidases Enzymes Will Be the Fastest Growing Segment in Glycomics Enzymes Market
  • Figure 29: North America Commands the Largest Share in Glycosidases Enzymes Market
  • Figure 30: North America Commands the Largest Share in Glycosyltransferases Enzymes Market
  • Figure 31: North America Commands the Largest Share in Neuraminidases Enzymes Market
  • Figure 32: North America Commands the Largest Share in Sialyltransferases Enzymes Market
  • Figure 33: North America Commands the Largest Share in Other Glycobiology Enzymes Market
  • Figure 34: Glycomic Instruments Market, By Products
  • Figure 35: Mass Spectrometry Instruments Will Be the Fastest Growing Segment in Glycobiology Instruments Market
  • Figure 36: North America Commands the Largest Share in Antibody Arrays Instruments Market
  • Figure 37: North America Commands the Largest Share in HPLC Instruments Market
  • Figure 38: North America Commands the Largest Share in Lectin Arrays Instruments Market
  • Figure 39: North America Commands the Largest Share in Maldi-TOF Instruments Market
  • Figure 40: North America Commands the Largest Share in Mass Spectrometery Instruments Market
  • Figure 41: North America Commands the Largest Share in Mass Spectrometery Instruments Market
  • Figure 42: Glycomic Kits Market, By Products
  • Figure 43: Glycan Release Kits Will Be the Fastest Growing Segment in Glycomics Kits Market
  • Figure 44: North America Commands the Largest Share in Glycan Labeling Kits Market
  • Figure 45: North America Commands the Largest Share in Glycan Purification Kits Market
  • Figure 46: North America Commands the Largest Share in Glycan Release Kits Market
  • Figure 47: North America Commands the Largest Share in Other Glycobiology Kits Market
  • Figure 48: Glycomic Reagents Market, By Products
  • Figure 49: Oligosaccharides Reagents Will Be the Fastest Growing Segment in Glycomics Reagents Market
  • Figure 50: North America Commands the Largest Share in Glycoproteins Reagents Market
  • Figure 51: North America Commands the Largest Share in Monosaccharides Reagents Market
  • Figure 52: North America Commands the Largest Share in Oligosaccharides Reagents Market
  • Figure 53: Europe Commands the Largest Share in Other Glycobiology Reagents Market
  • Figure 54: Glycomics Market Segmentation, By Application
  • Figure 55: Global Glycomics Market, By Application, 2014 (Market Size & Growth Rate)
  • Figure 56: Drug Discovery & Development Will Be the Fastest-Growing Application Segment of the Glycomics Market
  • Figure 57: North America to Command the Largest Share of the Diagnostics Segment
  • Figure 58: North America Commands the Largest Share in the Drug Discovery & Development Application Segment
  • Figure 59: Increase Research Application of Epigenetics in Immunology to Aid the Growth of This Application Segment
  • Figure 60: North America Commands the Largest Share in Immunology Owing to Increased Research Activities
  • Figure 61: North America to Command the Largest Share in Oncology Due to High Degree of Funding in Cancer Research in This Region
  • Figure 62: Europe Commands the Largest Share in the Other Applications Segment
  • Figure 63: Market Segmentation, By End User
  • Figure 64: Glycomics Market Size, By End User, 2014 (Market Size & Growth Rates)
  • Figure 65: Academic Research Institutes Will Be the Fastest-Growing End-User Segment
  • Figure 66: North America Will Be the Fastest-Growing Geographic Segment Due to Increased Funding for Glycobiology Research
  • Figure 67: Europe Will Be the Fastest-Growing Geographic Segment Due to Increasing Partnerships Between Research Institutes and Biotechnology Companies
  • Figure 68: Europe Will Be the Fastest-Growing Segment Due to Increased Outsourcing of Drug Discovery Research Activities to This Region
  • Figure 69: Geographic Snapshot (2014)
  • Figure 70: Asia Market Snapshot
  • Figure 71: Asia: Glycomics Market - By Product
  • Figure 72: Asia: Glycomics Market - By Product
  • Figure 73: China: Glycomics Market - By Product
  • Figure 74: India: Glycomics Market - By Product
  • Figure 75: Japan: Glycomics Market - By Product
  • Figure 76: Roa: Glycomics Market - By Product
  • Figure 77: Europe Market Snapshot
  • Figure 78: Europe: Glycomics Market - By Product
  • Figure 79: Europe: Glycomics Market - By Product
  • Figure 80: France: Glycomics Market - By Product
  • Figure 81: Germany: Glycomics Market - By Product
  • Figure 82: Italy: Glycomics Market - By Product
  • Figure 83: Spain: Glycomics Market - By Product
  • Figure 84: U.K.: Glycomics Market - By Product
  • Figure 85: Roe: Glycomics Market - By Product
  • Figure 86: North America Market Snapshot
  • Figure 87: North America: Glycomics Market - By Product
  • Figure 88: North America: Glycomics Market - By Product
  • Figure 89: Canada: Glycomics Market - By Product
  • Figure 90: U.S.: Glycomics Market - By Product
  • Figure 91: ROW Market Snapshot
  • Figure 92: ROW: Glycobiology Market - By Product
  • Figure 93: ROW: Glycomics Market - By Product
  • Figure 94: Middle East Nad Africa: Glycobiology Market - By Product
  • Figure 95: Pacific and Oceania: Glycomics - By Product
  • Figure 96: South America: Glycomics Market - By Product
  • Figure 97: Companies Adopted New Product Launches As A Key Growth Strategy
  • Figure 98: Global Glycomics Enzymes, Kits and Reagents (Excluding Instruments) Market Share Analysis, By Key Player, 2014
  • Figure 99: Global Glycomics Instruments Market Share Analysis, By Key Player, 2014
  • Figure 100: Battle for Market Share: New Product Launches Was the Key Strategy
  • Figure 101: Geographic Revenue Mix of Top 5 Market Players
  • Figure 102: Company Snapshot
  • Figure 103: SWOT Analysis
  • Figure 104: SWOT Analysis
  • Figure 105: Company Snapshot
  • Figure 106: SWOT Analysis
  • Figure 107: Company Snapshot
  • Figure 108: SWOT Analysis
  • Figure 109: Company Snapshot
  • Figure 110: SWOT Analysis
  • Figure 111: Company Snapshot
  • Figure 112: SWOT Analysis
  • Figure 113: Company Snapshot
  • Figure 114: Company Snapshot
  • Figure 115: Company Snapshot
Back to Top